Site-Specific Antibody for Protein Poly-ADP-Ribosylation
蛋白质聚 ADP 核糖基化位点特异性抗体
基本信息
- 批准号:10231962
- 负责人:
- 金额:$ 17.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:ADP ribosylationAmino Acid SequenceAnimal ModelAntibodiesAntigensAtlasesBRCA deficientBiological ProcessBiologyBreast Cancer CellBreast Cancer ModelBreast Cancer PatientCCAAT-Enhancer-Binding ProteinsCancer BiologyCell LineCell Membrane PermeabilityCell NucleusCellsCellular StressChemicalsClinicCommunitiesComplexComputer softwareDNADNA DamageDNA RepairDNA strand breakDataDatabasesDevelopmentEZH2 geneEnzymesEpitopesEquipmentEventFDA approvedFamilyFamily memberFutureGenotoxic StressHumanHydroxamic AcidsImmunoblottingImmunofluorescence ImmunologicImmunohistochemistryMalignant NeoplasmsMalignant neoplasm of ovaryMass Spectrum AnalysisMediatingMethodsModificationMusMutateNatureNuclearPTEN genePeptidesPoly(ADP-ribose) PolymerasesPost-Translational Protein ProcessingProceduresProductionPropertyProtein AnalysisProteinsProteomeProteomicsReactionResearchRibosomal ProteinsRoleSTK11 geneSignal TransductionSignaling ProteinSiteSystemTankyraseTimeTissue SampleTumor Suppressor ProteinsTumor TissueUrsidae FamilyVertebral columnXenograft Modelanalogaspartylglutamatebasebiological adaptation to stressbiomarker developmentcancer therapyclinically relevantcofactorcytotoxicdelta proteinexperimental studygenotoxicityinhibitor/antagonistinsightinstrumentationinterestlink proteinmalignant breast neoplasmmass spectrometermembernegative elongation factornovelrapid detectionrecruitresponsesuccesstargeted biomarkertool
项目摘要
Poly-ADP-ribosylation (PARylation) is a protein posttranslational modification (PTM) that is catalyzed by
a family of enzymes known as Poly-ADP-ribose polymerases (PARPs). Among the various PARP family
members, PARP1 is a nuclear enzyme that is critically involved in cell stress responses. Upon sensing DNA
strand breaks, PARP1 becomes activated, and then utilizes the cofactor, NAD+ to synthesize a large array of
PARylated proteins. These protein-linked PAR chains serve as a platform to recruit the DNA repair machinery,
and to initiate the DNA damage response (DDR). These findings provide the rationale to develop PARP1
inhibitors to treat human malignancies. Indeed, four PARP1 inhibitors have been recently approved by the FDA
to treat BRCA-deficient ovarian and/or breast cancer patients. Despite the exciting progresses of PARP1
inhibitors in the clinic, the basic signaling mechanism of PARP1 and the related PARP enzymes remains
poorly understood. The analysis of protein PARylation represents a daunting challenge, owing to the low-
abundance, labile and heterogeneous nature of this PTM. As a result, very few genuine PARP1 substrates
(and their modification sites) have been identified, and in most of the cases, how PARylation regulates the
function of the DNA damage responsive proteins is poorly defined. Recently, we developed the first large-scale
mass spectrometric (MS) approach towards site-specific characterization of protein Asp-/Glu-PARylation.
Although this strategy enables the quantitative assessment of the PARylated proteome, it is a quite lengthy
procedure that requires the access to both mass spectrometry equipment and computational proteomics
software. Furthermore, current anti-PAR antibodies only allow the analysis of the level of total PARylation, but
not PARylation at a specific residue. In this proposal, we will develop a chemical biology approach towards the
development of general site-specific PARylation antibodies. We will select a number of PARylation targets that
are critically involved in DDR, and the corresponding antibodies will be evaluated using cell systems and
animal models. We envision that the development of antibodies that allow for the simple, sensitive, specific and
rapid detection of PARylation sites would greatly facilitate the understanding the role of PARylation in DDR and
cancer. We also expect that this approach will be highly useful for the future development of biomarkers
targeting these aberrant “protein modification signatures”.
聚ADP核糖基化(PAR化)是一种蛋白质翻译后修饰(PTM),
称为聚ADP核糖聚合酶(PARP)的酶家族。在各个PARP家族中
成员们,PARP 1是一种核酶,在细胞应激反应中发挥重要作用。一旦感应到DNA
链断裂,PARP 1被激活,然后利用辅因子NAD+合成大量的
PAR化蛋白质。这些蛋白质连接的PAR链作为一个平台来招募DNA修复机制,
并启动DNA损伤反应(DDR)。这些发现为开发PARP 1提供了理论基础。
抑制剂来治疗人类恶性肿瘤。事实上,FDA最近批准了四种PARP 1抑制剂,
治疗BRCA缺陷的卵巢癌和/或乳腺癌患者。尽管PARP 1取得了令人兴奋的进展,
尽管PARP抑制剂在临床上的应用,但PARP 1和相关PARP酶的基本信号传导机制仍然存在,
不太了解。蛋白质PAR化的分析是一个艰巨的挑战,由于低-
这种PTM的丰度、不稳定性和异质性。因此,很少有真正的PARP 1底物
(and它们的修饰位点)已经被确定,并且在大多数情况下,PAR化如何调节
DNA损伤应答蛋白的功能还不清楚。最近,我们开发了第一个大规模的
质谱(MS)方法对蛋白质Asp-/Glu-PAR化的位点特异性表征。
虽然这种策略能够定量评估PAR化蛋白质组,但这是一个相当漫长的过程。
需要使用质谱仪和计算蛋白质组学的程序
软件此外,目前的抗PAR抗体仅允许分析总PAR化水平,但
而不是在特定残基上的PAR化。在本提案中,我们将开发一种化学生物学方法,
一般位点特异性PAR化抗体的开发。我们将选择一些PAR化靶点,
在DDR中起关键作用,相应的抗体将使用细胞系统进行评估,
动物模型我们设想,抗体的发展,允许简单,敏感,特异性和
PAR化位点的快速检测将极大地促进理解PAR化在DDR中的作用,
癌我们也期望这种方法对未来生物标志物的发展非常有用
针对这些异常的“蛋白质修饰特征”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yonghao Yu其他文献
Yonghao Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yonghao Yu', 18)}}的其他基金
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10524783 - 财政年份:2022
- 资助金额:
$ 17.39万 - 项目类别:
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10610165 - 财政年份:2022
- 资助金额:
$ 17.39万 - 项目类别:
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10389853 - 财政年份:2021
- 资助金额:
$ 17.39万 - 项目类别:
Site-Specific Antibody for Protein Poly-ADP-Ribosylation
蛋白质聚 ADP 核糖基化位点特异性抗体
- 批准号:
10610163 - 财政年份:2021
- 资助金额:
$ 17.39万 - 项目类别:
Posttranslational Regulation of Cell Growth and Stress Responses
细胞生长和应激反应的翻译后调节
- 批准号:
10676253 - 财政年份:2020
- 资助金额:
$ 17.39万 - 项目类别:
Posttranslational Regulation of Cell Growth and Stress Responses
细胞生长和应激反应的翻译后调节
- 批准号:
10610164 - 财政年份:2020
- 资助金额:
$ 17.39万 - 项目类别:
Mass spectrometric approaches to protein ADP-ribosylation
蛋白质 ADP 核糖基化的质谱方法
- 批准号:
9568790 - 财政年份:2017
- 资助金额:
$ 17.39万 - 项目类别:
Molecular and Biochemical Basis of mTORC1-mediated Feedback Loops
mTORC1 介导的反馈环的分子和生化基础
- 批准号:
9143156 - 财政年份:2015
- 资助金额:
$ 17.39万 - 项目类别:
Molecular and Biochemical Basis of mTORC1-mediated Feedback Loops
mTORC1 介导的反馈环的分子和生化基础
- 批准号:
9341365 - 财政年份:2015
- 资助金额:
$ 17.39万 - 项目类别:
相似海外基金
Cerebral infarction treatment strategy using collagen-like "triple helix peptide" containing functional amino acid sequence
含功能氨基酸序列的类胶原“三螺旋肽”治疗脑梗塞策略
- 批准号:
23K06972 - 财政年份:2023
- 资助金额:
$ 17.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of a screening method for functional microproteins independent of amino acid sequence conservation
不依赖氨基酸序列保守性的功能性微生物蛋白筛选方法的建立
- 批准号:
23KJ0939 - 财政年份:2023
- 资助金额:
$ 17.39万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Effects of amino acid sequence and lipids on the structure and self-association of transmembrane helices
氨基酸序列和脂质对跨膜螺旋结构和自缔合的影响
- 批准号:
19K07013 - 财政年份:2019
- 资助金额:
$ 17.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Construction of electron-transfer amino acid sequence probe with an interaction for protein and cell
蛋白质与细胞相互作用的电子转移氨基酸序列探针的构建
- 批准号:
16K05820 - 财政年份:2016
- 资助金额:
$ 17.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of artificial antibody of anti-bitter taste receptor using random amino acid sequence library
利用随机氨基酸序列库开发抗苦味受体人工抗体
- 批准号:
16K08426 - 财政年份:2016
- 资助金额:
$ 17.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The aa15-17 amino acid sequence in the terminal protein domain of HBV polymerase as a viral factor affect-ing in vivo as well as in vitro replication activity of the virus.
HBV聚合酶末端蛋白结构域中的aa15-17氨基酸序列作为影响病毒体内和体外复制活性的病毒因子。
- 批准号:
25461010 - 财政年份:2013
- 资助金额:
$ 17.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Amino acid sequence analysis of fossil proteins using mass spectrometry
使用质谱法分析化石蛋白质的氨基酸序列
- 批准号:
23654177 - 财政年份:2011
- 资助金额:
$ 17.39万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Precise hybrid synthesis of glycoprotein through amino acid sequence-specific introduction of oligosaccharide followed by enzymatic transglycosylation reaction
通过氨基酸序列特异性引入寡糖,然后进行酶促糖基转移反应,精确杂合合成糖蛋白
- 批准号:
22550105 - 财政年份:2010
- 资助金额:
$ 17.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Estimating selection on amino-acid sequence polymorphisms in Drosophila
果蝇氨基酸序列多态性选择的估计
- 批准号:
NE/D00232X/1 - 财政年份:2006
- 资助金额:
$ 17.39万 - 项目类别:
Research Grant
Construction of a neural network for detecting novel domains from amino acid sequence information only
构建仅从氨基酸序列信息检测新结构域的神经网络
- 批准号:
16500189 - 财政年份:2004
- 资助金额:
$ 17.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)